Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 16, 2023
March 16, 2023
2690554e-db22-4dd6-998e-50b04043d5ec
Related Documents
Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry
Guidance DocumentSeptember 20, 2018Center for Drug Evaluation and Research
Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act: Guidance for Industry
Guidance DocumentAugust 30, 2023Center for Drug Evaluation and Research
Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs: Guidance for Industry
Guidance DocumentDecember 7, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.